多模式预康复对衰弱老年胃癌患者临床结局的随机临床试验
这项在中国15个中心开展的随机临床试验纳入368例65-85岁衰弱(G8评分≤14)拟行根治性胃切除术的患者,比较ERAS联合多模式预康复与单纯ERAS的效果。改良意向治疗人群347例中,预康复组术后30天并发症发生率低于标准ERAS组(17.2% vs 28.7%,P=.01),且术前功能容量改善。
要点
- 衰弱老年胃癌患者根治术前接受至少2周多模式预康复可降低术后30天并发症率
- 预康复组小并发症和内科并发症均显著少于单纯ERAS组
- 预康复改善术前6分钟步行距离,术后4周仍高于基线水平
核心结论
- 多模式预康复可能增强衰弱老年胃癌根治术患者的生理储备、降低并发症率并促进手术恢复力。
研究设计与样本
- 随机临床试验,中国15个中心开展,2022年9月至2024年4月招募。
- 368例65-85岁衰弱(G8评分≤14)拟行择期胃切除术或新辅助化疗后胃切除术患者,1:1随机分入预康复联合ERAS组或标准ERAS组。
- 改良意向治疗人群347例(预康复组169例,标准ERAS组178例),预康复依从率93.75%。
主要发现
- 术后30天并发症发生率预康复组低于标准ERAS组(17.2% vs 28.7%,P=.01)。
- 小并发症:预康复组18/169例(10.7%)vs 标准ERAS组36/178例(20.2%),P=.01。
- 内科并发症:预康复组14/169例(8.3%)vs 标准ERAS组30/178例(16.9%),P=.02。
- 术前6分钟步行距离较基线平均变化+24(12.5)m,P<.001;术后4周平均步行距离仍高于基线。
- 慢性低度炎症、术前生理生活质量、ICU住院时间、机械通气时间和总住院时间等次要指标总体上倾向于预康复。
临床怎么用
- 对65-85岁衰弱(G8评分≤14)拟行根治性胃切除术的老年胃癌患者,可考虑在ERAS基础上加用至少2周多模式预康复。
- 预康复内容为多模式干预,具体方案需参照原始研究方案个体化实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Frailty is associated with functional decline and increased postoperative morbidity. Prehabilitation may complement Enhanced Recovery After Surgery (ERAS) care to improve patient outcomes. OBJECTIVE: To evaluate the effect of a multimodal prehabilitation program on functional capacity and clinical outcomes in older patients with frailty undergoing radical gastrectomy. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted at 15 centers in China. Participants aged 65 to 85 years with frailty (Geriatric 8 screening tool score ≤14) scheduled for elective gastrectomy or neoadjuvant chemotherapy prior to elective gastrectomy were randomized 1:1 to ERAS care either with or without prehabilitation. Recruitment for the study began in September 2022 and was completed in April 2024; data analysis was completed from September 2024 to April 2025. INTERVENTIONS: The prehabilitation group (PG) underwent multimodal prehabilitation for at least 2 weeks in combination with ERAS care, while the standard ERAS group (SG) followed a well-defined ERAS pathway. MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion of patients with postoperative complications within 30 days after surgery. Secondary outcomes included functional capacity, surgical resilience, and other short-term postoperative outcomes. RESULTS: A total of 368 participants were randomized to either the PG or SG group. In the modified intention-to-treat population of 347 participants (PG: n = 169; SG: n = 178), overall compliance with prehabilitation was 93.75%; median (IQR) participant age was 70 (68-73) years, and 95 participants (27.4%) were female. The rate of complications was lower in PG compared to SG (17.2% vs 28.7%; P = .01). In particular, significant benefits were observed in minor complications (PG: 18 of 169 patients [10.7%]; SG: 36 of 178 patients [20.2%]; P = .01) and medical complications (PG: 14 of 169 patients [8.3%]; SG: 30 of 178 patients [16.9%]; P = .02). The PG showed increased functional capacity before surgery compared to baseline (mean [SD] 6-minute walk test change, +24 [12.5] m; P < .001). Four weeks after surgery, the mean walking distance of the PG remained above baseline levels. Moreover, secondary parameters, such as chronic low-grade inflammation, preoperative physical quality of life, length of intensive care unit stay, mechanical ventilation time, and length of hospital stay, generally favored prehabilitation compared with standard ERAS care. CONCLUSIONS AND RELEVANCE: Per the results of this randomized clinical trial, a multimodal prehabilitation program may enhance physiological reserve, reduce morbidity, and promote surgical resilience in older patients with frailty undergoing radical gastrectomy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05352802.
引用
- Sun Y, Tian Y, Cao S, et al. Supervised Multimodal Prehabilitation and Clinical Outcomes in Older Patients With Frailty and Gastric Cancer: The GISSG+2201 Randomized Clinical Trial. JAMA Surg. 2026. PMID: 41604182. doi:10.1001/jamasurg.2025.6256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。